What are the recipes suitable for patients with nasopharyngeal carcinoma and what is the prognosis?

What is the diet for patients with nasopharyngeal carcinoma? What is the prognosis?

1. Nasopharyngeal carcinoma originates from the nasopharyngeal mucosal epithelium. The primary site is hidden and difficult to detect early. It has poor pathological differentiation and high malignancy.

2. Most patients with advanced nasopharyngeal cancer suffer from insufficient qi and blood, inflammation of toxic fire, and loss of appetite. Appetizing, stimulating appetite, and increasing intake are fundamental measures to ensure treatment. It is advisable to eat more foods that have anti-nasopharyngeal cancer effects, such as large leafy vegetables, taro, konjac, cucumber, dandelion, kiwi, toad, frog, pupae, snake meat, mussels, etc. Foods that are easy to digest, nutritious, and good in color, fragrance, and taste should be selected, such as porridge, soup, juice, etc. The deployment diet should be moist, delicious, fragrant, and turbid, such as rock sugar barley porridge, coriander stewed big carp, fresh pomegranate, fresh black plum, Guanggan, Chinese toon, pineapple, green plum, water chestnut, water chestnut, water chestnut, white pear, etc.

3. The mouth also contains Tibetan green fruit and fresh hawthorn, which have the effects of anti-inflammatory, sterilization, clearing the throat and promoting salivation. There is also ginsenoside Rh2. It has made a great contribution to the auxiliary treatment of nasopharyngeal carcinoma, inhibiting the proliferation of cancer cells, enhancing the sensitivity of chemotherapy drugs, reversing the drug resistance of tumor cells; reducing the side effects of radiotherapy and chemotherapy, preventing tumor recurrence and metastasis, anti-inflammatory, analgesic, improving sleep and appetite.

What is the prognosis for patients with nasopharyngeal carcinoma?

Nasopharyngeal carcinoma is mainly treated with radiotherapy, and residual lesions can be surgically removed. The irradiation range includes the nasopharynx, skull base, and neck orbit. The dose for the primary lesion is 65~70Gy, and the dose for the secondary lesion is 50~60Gy. Since the tumor is prone to recurrence and early metastasis, the prognosis is poor. The 5-year survival rate of squamous cell carcinoma, which is insensitive to radiation, is 0%~10%, and the 5-year survival rate of lymphoepithelioma, which is sensitive to radiation, is about 30%.